Thu, August 10, 2023
Wed, August 9, 2023
Tue, August 8, 2023

Judah Frommer Reiterated (ABOS) at Buy and Held Target at $13 on, Aug 9th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-13-on-aug-9th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Judah Frommer of Credit Suisse, Reiterated "Acumen Pharmaceuticals, Inc." (ABOS) at Buy and Held Target at $13 on, Aug 9th, 2023.

Judah has made no other calls on ABOS in the last 4 months.



There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Judah's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Judah


  • Geoff Meacham of "B of A Securities" Initiated at Strong Buy and Held Target at $14 on, Thursday, July 20th, 2023
  • Pete Stavropoulos of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $13 on, Monday, July 17th, 2023

Publication Contributing Sources